DGKα Enhances Tumorigenic Activity in Bladder Cancer Patients With Chronic Kidney Disease
Open Access
- 27 February 2025
- journal article
- Published by Wiley in Cancer Medicine
- Vol. 14 (5) , e70710
Abstract
Introduction: Chronic kidney disease (CKD) is a risk factor for bladder cancer (BC) and is reportedly involved in its recurrence and progression. This study aimed to determine the molecular mechanisms underlying the development of BC in patients with CKD.Methods: First, we generated the CKD mouse model according to a unilateral two‐stage renal ischemia–reperfusion injury protocol using wild‐type C57BL/6 mice. Second, we conducted a molecular functional analysis of DGKα in BC and investigated the contribution of DGKα to cell invasion, migration, and proliferation activity using human BC cell lines.Results: After confirming elevated serum creatinine levels in mice, the bladder was dissected, and mRNA sequencing of bladder urothelial cells was conducted. Gene expression profiling revealed remarkable upregulation in diacylglycerol kinase alpha (DGKα) level compared to that in control urothelial cells. DGKα‐knockdown cells displayed significantly decreased invasion, migration, and proliferation activity compared to the controls. Next, we conducted a clinical analysis of DGKα in BC patients and performed immunohistochemistry (IHC) on samples from patients treated with radical cystectomy. IHC staining revealed that DGKα‐positive cases had significantly worse recurrence‐free and cancer‐specific survival rates (p = 0.036 and = 0.003, respectively).Conclusion: DGKα expression is associated with tumorigenic activity in BC. Therefore, it is speculated that increased expression of DGKα in CKD cases is involved in the malignant potentials in BC. In conclusion, the crucial role of DGKα in BC is suggested, and it may be one of the factors contributing to poor prognosis in BC patients with CKD.Keywords
Funding Information
- Japan Society for the Promotion of Science (21K15506)
This publication has 28 references indexed in Scilit:
- Wee1 kinase as a target for cancer therapyCell Cycle, 2013
- Diacylglycerol Kinase α Is a Critical Signaling Node and Novel Therapeutic Target in Glioblastoma and Other CancersCancer Discovery, 2013
- Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras–Raf–MEK–ERK pathwayJournal of Hepatology, 2012
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- Diacylglycerol kinase α suppresses tumor necrosis factor-α-induced apoptosis of human melanoma cells through NF-κB activationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Activation of -diacylglycerol kinase is critical for the mitogenic properties of anaplastic lymphoma kinaseBlood, 2005
- Activation of HIF-prolyl Hydroxylases by R59949, an Inhibitor of the Diacylglycerol KinaseJournal of Biological Chemistry, 2005
- Activation of diacylglycerol kinase α is required for VEGF-induced angiogenic signaling in vitroOncogene, 2004
- Role of diacylglycerol induced by hypoxia in the regulation of HIF-1α activityBiochemical and Biophysical Research Communications, 2004
- Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homologCell, 1987